Latest Breaking News On - Ron waksman - Page 1 : comparemela.com

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Operators predict a shift in how they’ll treat in-stent restenosis, and maybe more, in coming years.

United kingdomUnited statesMedstar washington hospital centerDistrict of columbiaBeth israel medical centerNew yorkBritish columbiaRon waksmanJanar sathananthanMargaret mcentegartDrug administrationMd medstar washington hospital centerBoston scientificPresbyterian columbia university irving medical centerUs centers for medicareBeth israel deaconess medical center

World s First Patient Enrolled in SELUTION4DeNovo DEB IDE Trial

World s First Patient Enrolled in SELUTION4DeNovo DEB IDE Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesGeorgetown universityDistrict of columbiaEurope clinicaltrialsChris binghamSamink sharmaHellman friedmanRon waksmanMedalliance coronary study steering committeeCardiovascular research at medstar heartVascular instituteProfessor of cardiology at georgetown universityDrug eluting balloonDevice exemptionInterventional cardiology

Cordis Announces the Completed Acquisition of MedAlliance

/PRNewswire/ Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announced.

Switzerland generalRon waksmanChris binghamHellman friedmanWashington hospital centerSustained limus releaseDrug eluting balloonsShar matinPrimary investigatorGlobal marketing

Cordis Announces the Completed Acquisition of MedAlliance

MIAMI LAKES, Fla., Oct. 3, 2023 /PRNewswire/ Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular a.

Switzerland generalRon waksmanChris binghamHellman friedmanWashington hospital centerSustained limus releaseDrug eluting balloonsShar matinPrimary investigatorGlobal marketing

Novel Bioadaptable Stent Noninferior to DES, With Advantages

A new device called bioadaptable, as opposed to bioabsorbable, was noninferior to a widely used drug eluting stent, and associated with several vessel functional improvements, in the BIOADAPTER trial.

New zealandUnited statesRon waksmanShigero saitoEuropean association of percutaneous cardiovascular interventionsMedstar hospital centerShonan kamakuraEuropean associationPercutaneous cardiovascular interventionsElixir medicalMyocardial infarctionDrug eluting stentCoronary stentHealthcare and medical technologyEalth and medical techEalth and med tech